65-5601. Definitions. As used in K.S.A. 65-5601 through 65-5605, and amendments thereto: (a) “Patient” means a person who consults or is examined or interviewed by treatment personnel. (b) “Treatment personnel” means any employee of a treatment facility who receives a confidential communication from a patient while engaged in the diagnosis or treatment of a mental, […]
65-5602. Privilege of patient of treatment facility to prevent disclosure of treatment and of confidential communications; extent of privilege; persons who may claim privilege; persons to which confidential communications extend. (a) A patient of a treatment facility has a privilege to prevent treatment personnel or ancillary personnel from disclosing that the patient has been or […]
65-5603. Exceptions to privilege. (a) The privilege established by K.S.A. 65-5602, and amendments thereto, shall not extend to: (1) Any communication relevant to an issue in proceedings to involuntarily commit to treatment a patient for mental illness, alcoholism or drug dependency if the treatment personnel in the course of diagnosis or treatment has determined that […]
65-5604. Interpretation of act; rules of discovery not to take precedence over act. This act shall be interpreted to encourage treatment in a confidential setting and the rules of discovery shall not take precedence over the provisions of this act. History: L. 1986, ch. 212, § 4; July 1.
65-5605. Violations; misdemeanor. Any treatment personnel or ancillary personnel willfully violating the patient’s confidentiality as defined by this act shall be guilty of a class C misdemeanor. History: L. 1986, ch. 212, § 5; July 1.
